Development of surface-engineered PLGA nanoparticulate-delivery system of Tet-1-conjugated nattokinase enzyme for inhibition of Aβ40 plaques in Alzheimer’s disease
Prakash Chandra Bhatt,1 Amita Verma,2 Fahad A Al-Abbasi,3 Firoz Anwar,3 Vikas Kumar,4 Bibhu Prasad Panda1 1Microbial and Pharmaceutical Biotechnology Laboratory, Centre for Advanced Research in Pharmaceutical Science, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India; 2Bioorganic & Medic...
Guardado en:
Autores principales: | Bhatt PC, Verma A, Al-Abassi FA, Anwar F, Kumar V, Panda BP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2f969dbd08b948ea8431d7227a60c147 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Harnessing efficient multiplex PCR methods to detect the expanding Tet(X) family of tigecycline resistance genes
por: Kai Ji, et al.
Publicado: (2020) -
The hepatic AMPK-TET1-SIRT1 axis regulates glucose homeostasis
por: Chunbo Zhang, et al.
Publicado: (2021) -
Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine
por: Jahan ST, et al.
Publicado: (2018) -
Effect of Fermentation Parameters on Natto and Its Thrombolytic Property
por: Yun Yang, et al.
Publicado: (2021) -
Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression
por: Qi Wang, et al.
Publicado: (2019)